In animal models of melanoma, CBL0137 reverses anti-PD-1 resistance by promoting ZBP1-RIPK3-dependent necroptosis and driving CD8+ T cell recruitment (Zhang et al., 2022b). This evidence concerns the gene PDCD1 and melanoma.